CDH11

CDH11
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases CDH11, CAD11, CDHOB, OB, OSF-4, cadherin 11
External IDs MGI: 99217 HomoloGene: 1361 GeneCards: CDH11
RNA expression pattern


More reference expression data
Orthologs
Species Human Mouse
Entrez

1009

12552

Ensembl

ENSG00000140937

ENSMUSG00000031673

UniProt

P55287

P55288

RefSeq (mRNA)

NM_001308392
NM_001797

NM_009866

RefSeq (protein)

NP_001295321.1
NP_001788.2

NP_033996.4

Location (UCSC) Chr 16: 64.94 – 65.13 Mb Chr 8: 102.63 – 102.79 Mb
PubMed search [1] [2]
Wikidata
View/Edit HumanView/Edit Mouse

Cadherin-11 is a protein that in humans is encoded by the CDH11 gene.[3][4]

Function

This gene encodes a type II classical cadherin from the cadherin superfamily, integral membrane proteins that mediate calcium-dependent cell-cell adhesion. Mature cadherin proteins are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. Expression of this particular cadherin in osteoblastic cell lines, and its upregulation during differentiation, suggests a specific function in bone development and maintenance.[4] The mammalian CDH-11 homologues are termed calsyntenin.[5]

Relevance to cancer

CDH11 is overexpressed in 15% of breast cancers and seems essential to tumour progression in some other cancer types.[6][7]

Drug interactions

Arthritis drug celecoxib binds to CDH11.[6][7]

Interactions

CDH11 has been shown to interact with CDH2.[8]

References

  1. "Human PubMed Reference:".
  2. "Mouse PubMed Reference:".
  3. Kremmidiotis G, Baker E, Crawford J, Eyre HJ, Nahmias J, Callen DF (Aug 1998). "Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity". Genomics. 49 (3): 467–71. doi:10.1006/geno.1998.5281. PMID 9615235.
  4. 1 2 "Entrez Gene: CDH11 cadherin 11, type 2, OB-cadherin (osteoblast)".
  5. Vogt L, Schrimpf SP, Meskenaite V, Frischknecht R, Kinter J, Leone DP, Ziegler U, Sonderegger P (2001). "Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain". Mol. Cell. Neurosci. 17 (1): 151–66. doi:10.1006/mcne.2000.0937. PMID 11161476.
  6. 1 2 "New Therapeutic Approach Could Target Both Cancer and Arthritis". 15 Nov 2013.
  7. 1 2 Assefnia S, Dakshanamurthy S, Guidry Auvil JM, Hampel C, Anastasiadis PZ, Kallakury B, Uren A, Foley DW, Brown ML, Shapiro L, Brenner M, Haigh D, Byers SW (Mar 2014). "Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies.". Oncotarget. 5 (6): 1458–74. PMID 24681547.
  8. Straub BK, Boda J, Kuhn C, Schnoelzer M, Korf U, Kempf T, Spring H, Hatzfeld M, Franke WW (Dec 2003). "A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells". J. Cell. Sci. 116 (Pt 24): 4985–95. doi:10.1242/jcs.00815. PMID 14625392.

Further reading

External links


This article is issued from Wikipedia - version of the 5/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.